Trademark: 88347143
Word
CT360
Status
Registered
Status Code
700
Status Date
Tuesday, October 29, 2019
Serial Number
88347143
Registration Number
5895055
Registration Date
Tuesday, October 29, 2019
Mark Type
4000
Filing Date
Tuesday, March 19, 2019
Published for Opposition
Tuesday, August 13, 2019

Trademark Owner History
Celgene Corporation - Original Registrant

Classifications
9 Downloadable computer software enabling patients to manage and access data relating to the treatment of cancer and immunological disorders; downloadable computer application software for use on mobile phones and mobile electronic devices for use in connection with providing medical information in the field of cancer and immunological disorders; downloadable electronic publications, namely, newsletters and articles featuring medical information in the field of cancer and immunological disorders; downloadable videos featuring medical information in the field of cancer and immunological disorders; downloadable computer software for application and database integration
5 Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy
36 Financial administration of patient reimbursement programs; financial administration of medication reimbursement programs and services
45 Providing patient advocate services in the field of the treatment of diseases and disorders
44 Providing medical information; providing health information in the field of oncology and immunological disorders; providing a web site featuring medical information; providing a web site featuring health information in the field of oncology and immunological disorders; providing medical information, consultancy and advisory services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
42 Software as a Service (SaaS) services featuring software that allows patients to manage and access data relating to the treatment of cancer and immunological disorders; application service provider (ASP) featuring software for medical affair management and information exchange; providing a website featuring non-downloadable software for medical affair management and information exchange; providing an on-line computer database featuring medical and scientific research information in the field of cancer and immunological disorders that allows for input and collection of scientific and research data and information; medical and scientific research liaison services, namely, consulting in the field of scientific research pertaining to clinical trials in the fields of health care, medicine, pharmacology and biotechnology; scientific research consultation pertaining to clinical trials; providing medical and scientific research information in the field of clinical trials

Trademark Events
Dec 9, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 9, 2022
Teas Change Of Correspondence Received
Dec 9, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Dec 9, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 9, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 9, 2022
Teas Change Of Owner Address Received
Oct 29, 2019
Registered-Principal Register
Aug 13, 2019
Official Gazette Publication Confirmation E-Mailed
Aug 13, 2019
Published For Opposition
Jul 24, 2019
Notification Of Notice Of Publication E-Mailed
Jul 5, 2019
Approved For Pub - Principal Register
Jul 5, 2019
Examiner's Amendment Entered
Jul 5, 2019
Notification Of Examiners Amendment E-Mailed
Jul 5, 2019
Examiners Amendment E-Mailed
Jul 5, 2019
Examiners Amendment -Written
Jul 3, 2019
Teas/Email Correspondence Entered
Jul 3, 2019
Correspondence Received In Law Office
Jul 1, 2019
Teas Voluntary Amendment Received
Jun 24, 2019
Teas/Email Correspondence Entered
Jun 24, 2019
Correspondence Received In Law Office
Jun 21, 2019
Teas Response To Suspension Inquiry Received
May 1, 2019
Notification Of Letter Of Suspension E-Mailed
May 1, 2019
Letter Of Suspension E-Mailed
May 1, 2019
Suspension Letter Written
May 1, 2019
Examiner's Amendment Entered
May 1, 2019
Notification Of Examiners Amendment E-Mailed
May 1, 2019
Examiners Amendment E-Mailed
May 1, 2019
Examiners Amendment -Written
Apr 28, 2019
Assigned To Examiner
Apr 7, 2019
New Application Office Supplied Data Entered In Tram
Mar 30, 2019
Preliminary/Voluntary Amendment - Entered
Mar 28, 2019
Assigned To Lie
Mar 22, 2019
Teas Voluntary Amendment Received
Mar 22, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24